Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Other financing activities (2018 - 2025)

Neuronetics (STIM) has disclosed Other financing activities for 7 consecutive years, with -$1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other financing activities changed N/A to -$1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $516000.0, a N/A change, with the full-year FY2024 number at $2.6 million, up 137.68% from a year prior.
  • Other financing activities was -$1.7 million for Q3 2025 at Neuronetics, down from $1.7 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.7 million in Q1 2025 to a low of -$1.7 million in Q3 2025.
  • A 5-year average of $211200.0 and a median of $151500.0 in 2023 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: plummeted 85.79% in 2022, then soared 24000.0% in 2023.
  • Neuronetics' Other financing activities stood at $401000.0 in 2021, then tumbled by 99.75% to $1000.0 in 2022, then skyrocketed by 24000.0% to $241000.0 in 2023, then soared by 80.91% to $436000.0 in 2024, then crashed by 478.67% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Other financing activities are -$1.7 million (Q3 2025), $1.7 million (Q1 2025), and $436000.0 (Q4 2024).